NCMS Morning Rounds 8-22-19

Happy Thursday! Here is your

 NCMS Morning Rounds.

Aug. 22, 2019

SCAM ALERT: Callers Masquerading as NC Medical Board Seek Personal Data

Telephone scammers are getting more sophisticated. Recently the North Carolina Medical Board (NCMB) learned scammers are spoofing the Board’s main telephone number to make their calls appear legitimate. Scammers typically threaten loss of the target’s professional license if personal or financial information is not provided.

Be advised:

  • NCMB does NOT contact licensees by telephone to give notice of pending action, and does not demand payment or sensitive information by phone, such as DEA number or NPI number.
    • If you receive a suspicious phone call, hang up; do NOT release any personal information.
    • If you have questions, please send an email to: or call 1-800-253-9653.

Please encourage colleagues to be aware and cautious.

PCPI Offers Guide to ‘Harmonizing’ Performance Measures

The Physician Consortium for Performance Improvement (PCPI) recently released the Performance Measure Harmonization Guide, which helps health care teams evaluate performance measures to ensure they are not duplicative or require a lot of effort to implement. PCPI brings together a variety of health care stakeholders to improve performance measurement to improve the health care delivery system. This guide offers potential areas to bring harmony to performance measurement projects or as PCPI states: “Without a common approach to measure harmonization, each measure development effort starts from scratch, without leveraging work already completed, and creates a plethora of seemingly similar, yet different measure concepts.” Access the guide.

NCMS Senior Vice President for Health System Innovation and Deputy General Counsel Melanie Phelps, JD, serves on the PCPI Board of Directors.

Pfizer Announces Major Investment in Gene Therapy Manufacturing in NC

Yesterday, NCMS representatives were present when Pfizer announced it would be investing an additional half billion dollars in the construction of a state-of-the-art gene therapy manufacturing facility in Sanford, NC. This facility would expand the company’s presence in the state, adding approximately 300 new jobs to 650 current employees working in Sanford. Pfizer employs a total of 3,600 people in North Carolina.

In addition to gene therapy, the Sanford facility also will manufacture components for Pfizer’s vaccine portfolio, including Prevnar 13. Pfizer hopes this expansion project will strengthen its ability to produce and supply both clinical- and commercial-scale quantities of gene therapy medicine to patients living with rare diseases

In the News

It’s Not All About the Patient, Vidant Health CXO Says, Becker’s Hospital Review, 8-15-19

Learning Opportunity

The NC Chamber Health Care Conference will be held Sept. 20 at the Sheraton Imperial Hotel & Convention Center in Durham. The conference seeks to bring together health care experts and leaders from various industries to effectively transform our state’s health care delivery system. Patrick Conway, MD, the CEO of Blue Cross and Blue Shield of NC and NC Department of Health and Human Services Secretary Mandy Cohen, MD, MPH, will speak. Learn more and register.


More Posts in Morning Rounds


Share this Post